China-New Zealand Joint Laboratory on Biomedicine and Health, CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Centre for Regenerative Medicine and Health, Hong Kong Institute of Science and Innovation, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Nucleic Acids Res. 2022 May 20;50(9):5384-5399. doi: 10.1093/nar/gkac353.
Establishing saturated mutagenesis in a specific gene through gene editing is an efficient approach for identifying the relationships between mutations and the corresponding phenotypes. CRISPR/Cas9-based sgRNA library screening often creates indel mutations with multiple nucleotides. Single base editors and dual deaminase-mediated base editors can achieve only one and two types of base substitutions, respectively. A new glycosylase base editor (CGBE) system, in which the uracil glycosylase inhibitor (UGI) is replaced with uracil-DNA glycosylase (UNG), was recently reported to efficiently induce multiple base conversions, including C-to-G, C-to-T and C-to-A. In this study, we fused a CGBE with ABE to develop a new type of dual deaminase-mediated base editing system, the AGBE system, that can simultaneously introduce 4 types of base conversions (C-to-G, C-to-T, C-to-A and A-to-G) as well as indels with a single sgRNA in mammalian cells. AGBEs can be used to establish saturated mutant populations for verification of the functions and consequences of multiple gene mutation patterns, including single-nucleotide variants (SNVs) and indels, through high-throughput screening.
通过基因编辑在特定基因中建立饱和诱变是鉴定突变与相应表型之间关系的有效方法。基于 CRISPR/Cas9 的 sgRNA 文库筛选通常会产生具有多个核苷酸的缺失/插入突变。单碱基编辑器和双脱氨酶介导的碱基编辑器分别只能实现一种和两种类型的碱基替换。最近报道了一种新的糖苷酶碱基编辑器 (CGBE) 系统,其中尿嘧啶糖基化酶抑制剂 (UGI) 被尿嘧啶-DNA 糖基化酶 (UNG) 取代,该系统可有效诱导多种碱基转换,包括 C 到 G、C 到 T 和 C 到 A。在这项研究中,我们将 CGBE 与 ABE 融合,开发了一种新型的双脱氨酶介导的碱基编辑系统,即 AGBE 系统,该系统可以在哺乳动物细胞中通过单个 sgRNA 同时引入 4 种碱基转换(C 到 G、C 到 T、C 到 A 和 A 到 G)以及缺失/插入。AGBEs 可用于建立饱和突变体群体,通过高通量筛选验证多种基因突变模式(包括单核苷酸变异 (SNV) 和缺失/插入)的功能和后果。